Jpmorgan Chase & CO Emergent Bio Solutions Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 213,747 shares of EBS stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
213,747
Previous 434 49150.46%
Holding current value
$1.9 Million
Previous $4,000 25850.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$4.66 - $11.66 $994,038 - $2.49 Million
213,313 Added 49150.46%
213,747 $1.04 Million
Q4 2024

Feb 12, 2025
SELL
$7.72 - $11.97 $1,613 - $2,501
-209 Reduced 32.5%
434 $4,000
Q3 2024

Dec 26, 2024
SELL
$5.72 - $14.77 $3.71 Million - $9.58 Million
-648,859 Reduced 99.9%
643 $5,000
Q3 2024

Nov 08, 2024
SELL
$5.72 - $14.77 $3.71 Million - $9.58 Million
-648,859 Reduced 99.9%
643 $5,000
Q2 2024

Dec 26, 2024
BUY
$1.86 - $6.98 $1.21 Million - $4.53 Million
648,859 Added 100911.2%
649,502 $4.43 Million
Q2 2024

Aug 12, 2024
BUY
$1.86 - $6.98 $699,289 - $2.62 Million
375,962 Added 137.44%
649,502 $4.43 Million
Q1 2024

Dec 26, 2024
BUY
$1.5 - $3.41 $409,345 - $930,578
272,897 Added 42441.21%
273,540 $692,000
Q1 2024

May 10, 2024
BUY
$1.5 - $3.41 $333,874 - $759,008
222,583 Added 436.81%
273,540 $692,000
Q4 2023

Dec 26, 2024
BUY
$1.82 - $3.16 $91,571 - $158,992
50,314 Added 7824.88%
50,957 $122,000
Q4 2023

Feb 12, 2024
SELL
$1.82 - $3.16 $440 - $764
-242 Reduced 0.47%
50,957 $122,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $7.91 $24,913 - $62,164
7,859 Added 18.13%
51,199 $174,000
Q2 2023

Aug 11, 2023
SELL
$7.35 - $13.21 $196,399 - $352,984
-26,721 Reduced 38.14%
43,340 $318,000
Q1 2023

May 18, 2023
BUY
$7.79 - $16.29 $469,900 - $982,629
60,321 Added 619.31%
70,061 $725,000
Q1 2023

May 11, 2023
SELL
$7.79 - $16.29 $1.83 Million - $3.82 Million
-234,503 Reduced 96.01%
9,740 $100,000
Q4 2022

Feb 13, 2023
BUY
$11.0 - $21.45 $1.99 Million - $3.89 Million
181,213 Added 287.5%
244,243 $2.88 Million
Q3 2022

Nov 14, 2022
SELL
$20.09 - $35.8 $2.09 Million - $3.73 Million
-104,184 Reduced 62.31%
63,030 $1.32 Million
Q2 2022

Aug 11, 2022
BUY
$27.42 - $43.63 $230,903 - $367,408
8,421 Added 5.3%
167,214 $5.19 Million
Q1 2022

May 11, 2022
BUY
$36.48 - $52.22 $4.05 Million - $5.79 Million
110,909 Added 231.62%
158,793 $6.52 Million
Q4 2021

Feb 10, 2022
SELL
$33.11 - $55.01 $1.56 Million - $2.59 Million
-47,003 Reduced 49.54%
47,884 $2.08 Million
Q3 2021

Nov 12, 2021
BUY
$50.07 - $66.05 $4.75 Million - $6.27 Million
94,887 New
94,887 $4.75 Million

Others Institutions Holding EBS

# of Institutions
188
Shares Held
39.4M
Call Options Held
299K
Put Options Held
157K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $444M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email